US 10799461
Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
granted A61KA61K31/704A61K47/6879
Quick answer
US patent 10799461 (Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells) held by EnGeneIC Molecular Delivery Pty Ltd expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- EnGeneIC Molecular Delivery Pty Ltd
- Grant date
- Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/704, A61K47/6879, A61K47/6901, A61K9/5068